This section includes articles and columns on outsourcing, including analysis of industry outsourcing trends and practical articles on handling aspects of outsourcings such as technology transfer, contract negotiation, project management, auditing providers, and outsourcing abroad. We include a special focus on the developments of the biopharmaceutical industry in China, and issues related to outsourcing to China.
October 1, 2009
By:Jim Miller
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
 |
August 1, 2009
By:Jim Miller
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
|
June 1, 2009
By:Jim Miller
UK-based CMOs seek opportunities in new markets.
|
May 1, 2009
By:Jim Miller
The current competitive environment is forcing service providers to evaluate their business models and focus on value and performance.
|
February 1, 2009
By:Jim Miller
What the current lack of venture capital means for the CRO market.
|
December 1, 2008
By:Stephanie Morris
Four reasons why outsourcing may be the best option, and key factors to consider when selecting a provider.
|
November 1, 2008
By:Jim Miller
There could be a serious glut of commercial scale mammalian cell culture capacity over the next five years. Then again, there could be a significant shortage. It all depends on how things develop in expression technology, the new product pipeline, and corporate strategies.
|
September 1, 2008
By:Jim Miller
Risk mitigation should be a key aspect of any contract manufacturing organization's business strategy.
|
May 1, 2008
By:Jim Miller
The current overcapacity situation in the bio/pharmaceutical industry is a reminder that CMOs need to come up with business models and value propositions that are based on more than just selling capacity.
|
| 
